Author

K. Schulze-Osthoff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

A. Flechtner· 1 shared A. Sarkar· 1 shared A. Stenzinger· 1 shared B. Obermayer· 1 shared C. H. Brandts· 1 shared C. Messerschmidt· 1 shared D. Beule· 1 shared D. T. Rieke· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Flechtner

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

IκBζ is constitutively expressed in human and murine airway epithelium

K. Sundaram, S. Mitra, F. Jaynes, S. Lorscheid, H. Steiner, A. Flechtner, A. Sarkar, K. Shilo, P. N. Boyaka, K. Schulze-Osthoff, M. D. Wewers

The paper investigates IκBζ expression in human and murine airway epithelium, finding constitutive expression that may support lung host defense.

bioRxiv · Mar 29, 2019 · PreprintImmunology

Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC

C. Messerschmidt, B. Obermayer, K. Klinghammer, S. Ochsenreither, D. Treue, A. Stenzinger, H. Glimm, S. Fröhling, T. Kindler, C. H. Brandts, K. Schulze-Osthoff, W. Weichert, I. Tinhofer, F. Klauschen, U. Keilholz, , D. T. Rieke

The paper identifies an APOBEC-enriched subgroup of HPV-negative HNSCC with distinct immunogenic features linked to immune evasion and potential response to immunotherapy.

bioRxiv · Mar 28, 2019Cancer Biology